NCT02260934: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 1 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02260934 |
|---|---|
| Title | Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis (ITN055AI) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 9, 2015 |
| Completion date | March 12, 2018 |
| Required reporting date | March 12, 2019, midnight |
| Actual reporting date | March 13, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 1 |